Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization-Reference-Cited by-同舟云学术

Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization

Published:2020-03-18 Issue:6 Volume:10 Page:806-821
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Liu Zhaoqi,Yoshimi Akihide^ORCID,Wang Jiguang^ORCID,Cho Hana,Chun-Wei Lee Stanley,Ki Michelle,Bitner Lillian,Chu Timothy,Shah Harshal^ORCID,Liu Bo,Mato Anthony R.,Ruvolo Peter,Fabbri Giulia,Pasqualucci Laura,Abdel-Wahab Omar,Rabadan Raul

Funder

NIH

Aplastic Anemia

MDS International Foundation

Lauri Strauss Leukemia Foundation

JSPS

Leukaemia and Lymphoma

NIHNCINCI

American Society of Hematology

NIHNHLBINHLBI

Department of Defense

Starr Foundation

Henry & Marilyn Taub Foundation

Edward P. Evans Foundation

Leukemia and Lymphoma Society

Pershing Square Sohn Cancer Research Alliance

NSFSU2CV FoundationSU2CV Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing;Pharmacology & Therapeutics;2024-09

2. Molecular impact of mutations in RNA splicing factors in cancer;Molecular Cell;2024-08

3. The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts;Blood Advances;2024-07-26

4. Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma;Advanced Science;2024-07-17

5. Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors;Nature Communications;2024-06-18